Skip to main content

Lisinopril

NDC 72865-209 · XLCare Pharmaceuticals Inc.

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength5 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

72865-209-01 — 100 TABLET in 1 BOTTLE (72865-209-01)

72865-209-10 — 1000 TABLET in 1 BOTTLE (72865-209-10)

72865-209-45 — 45 TABLET in 1 BOTTLE (72865-209-45)

72865-209-90 — 90 TABLET in 1 BOTTLE (72865-209-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-733 — LISINOPRIL, 71610-741 — Lisinopril, 71610-748 — LISINOPRIL, 71610-766 — LISINOPRIL, 71610-838 — Lisinopril and Hydrochlorothiazide, 71610-868 — Lisinopril and Hydrochlorothiazide Tablets, 72189-651 — Lisinopril/HCTZ, 72789-093 — Lisinopril, 72789-101 — Lisinopril, 72865-208 — Lisinopril, 72865-210 — Lisinopril, 72865-211 — Lisinopril, 72865-212 — Lisinopril, 72865-213 — Lisinopril, 76282-417 — lisinopril, 76282-418 — lisinopril, 76282-419 — lisinopril, 76282-420 — lisinopril, 76282-421 — lisinopril, 76282-422 — lisinopril, +342 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels